Professor Toshio Shimizu has been appointed as the Chairperson of the 38th Forum for the Development of Anticancer Agents, titled “The Power of Industry-Academia-Government Co-Creation – Innovation and Implementation of Anticancer Drug Development Using Real-World Data (RWD)”, taking place on 28 June 2025 in Tokyo, Japan.

第38回抗悪性腫瘍薬開発フォーラム 『アジアの中の日本の立ち位置〜日本がリーダーになるために〜』
The forum, themed “Japan’s Position in Asia – Toward Becoming a Global Leader,” brings together leading experts from industry, government, and academia to engage in in-depth discussions on the current frontiers of RWD and its application in drug development.

Topics covered will include:
•Global and domestic trends in RWD utilization
•Japan’s challenges with drug loss and drug lag
•Status and challenges in building reliable and applicable RWD
•New initiatives under the Next-Generation Medical Infrastructure Act
•Case studies of RWD use in regulatory submissions and clinical trials by pharmaceutical companies
•Utilization of data from insurance-covered cancer gene panel testing
•Regulatory perspectives on RWD utilization, including insights from the PMDA

This forum presents an exceptional opportunity to deepen understanding of how real-world data drives innovation and practical implementation in developing anticancer agents. The program aims to explore how RWD is transforming the landscape of oncology drug development through the latest technological trends, regulatory updates, and real-life examples.